Phenotypic assays demonstrated that the effects of a mutated SET domain largely overlap those of SMYD3 silencing, meaning that a functional SET domain is necessary for PCa cell lines malignant phenotype. The gene discussed is SET; the disease is posterior cortical atrophy.